Fibroindex, a simple noninvasive test forprediction of fibrosis in patients withchronic hepatitis C virus infection

Assessment of fibrosis biomarkers alone and incombination with tissue harmonic imaging versushistopathological fibrosis scoring in patients withchronic HCV infection and /or NASH

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Comparative study between liver biopsy versus fibroscan in chronic hepatitis C virus patients

Correlation of ultrasonographic findings with histopathological diagnosis in HCV related chronic liver diseases

Diagnosis and staging of hepatic fibrosis by ultrasound elastography in patients with chronic liver diseases

Metaanalysis of non invasive assessment of liver fibrosis :Applications and limitations

Evaluation of ultrasonic transient elastography (fibroscan) in Egyptian chronic HCV patients